Li, Zhaoyang http://orcid.org/0000-0003-4625-1107
Follman, Kristin
Freshwater, Ed
Engler, Frank
Yel, Leman http://orcid.org/0000-0001-8357-3186
Funding for this research was provided by:
Takeda Development Center Americas, Inc.
Article History
Received: 14 April 2023
Accepted: 18 August 2023
First Online: 29 September 2023
Declarations
:
: This study utilized population pharmacokinetic modeling and simulation; as such, no ethics approval was required.
: This study utilized population pharmacokinetic modeling and simulation; as such, there were no human participants.
: This study utilized population pharmacokinetic modeling and simulation; as such, there were no human participants.
: ZL is an employee of Takeda Development Center Americas, Inc., and a Takeda shareholder. EF, FE, and KF are employees of Certara USA and have received research grants from Takeda Development Center Americas, Inc., for this study. LY is a Takeda shareholder and was an employee of Takeda Development Center Americas, Inc., at the time of the study.